MedMesh.i
Corpus
PubMed
Racine
Corpus
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Monoamine Oxidase Inhibitors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Monoamine Oxidase < Monoamine Oxidase Inhibitors < Monocytes  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000218 (2016) Santiago Perez-Lloret ; Olivier RascolThe safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease.
000600 (????) Romain Lefaucheur ; Damien Fetter ; Gaëlle Gaillon ; Alaina Borden ; David MaltêteTendon rupture as an adverse effect of rasagiline.
000788 (2013) François Viallet ; Séverine Pitel ; Sylvie Lancrenon ; Olivier BlinEvaluation of the safety and tolerability of rasagiline in the treatment of the early stages of Parkinson's disease.
000E26 (2006) Rasagiline. Parkinson's disease: a simple me-too.
000F59 (????) O. Rascol ; D J Brooks ; E. Melamed ; W. Oertel ; W. Poewe ; F. Stocchi ; E. TolosaRasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
001118 (2003) Olivier RascolMonoamine oxidase inhibitors--is it time to up the TEMPO?
001175 (2002) Selegiline: a second look. Six years later: too risky in Parkinson's disease.
001654 (1994) A. Boireau ; P. Dubédat ; F. Bordier ; C. Peny ; J M Miquet ; G. Durand ; M. Meunier ; A. DobleRiluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice.
001693 (1994) J C Delumeau ; D. Bentué-Ferrer ; J M Gandon ; R. Amrein ; S. Belliard ; H. AllainMonoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases.
001854 (1989) M. Zreika ; J R Fozard ; M W Dudley ; P. Bey ; I A Mcdonald ; M G PalfreymanMDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Monoamine Oxidase Inhibitors" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Monoamine Oxidase Inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Monoamine Oxidase Inhibitors
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024